This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dorigo, B. Articles by Mosconi, G. Search for Related Content PubMed PubMed Citation Articles by Dorigo, B. Articles by Mosconi, G. Social Bookmarking                         What's this?

Efficacy of Femoral Intra-arterial Administration of Teicoplanin in Gram-Positive Diabetic Foot Infections

Institute of Internal Medicine , University of Florence, Florence, Italy

Anna Maria Cameli

Institute of Internal Medicine , University of Florence, Florence, Italy

Maurizio Trapani

Institute of Internal Medicine , University of Florence, Florence, Italy

Dinella Raspanti

Institute of Internal Medicine , University of Florence, Florence, Italy

Marco Torri

Institute of Internal Medicine , University of Florence, Florence, Italy

Giorgio Mosconi

Marion Merrell Dow Inc., Medical Department, Zürich, Switzerland

In this study the efficacy and safety femoral intra-arterial administration of teicoplanin in the treatment of diabetic foot infections caused by gram-positive bacteria were evaluated. Twenty-five hospitalized diabetic patients with foot ulcers or with foot ulcers and metatarsophalangeal osteomyelitis were included in the study.

In the ulcers Staphylococcus aureus was present alone in 16 patients and was associ ated with Pseudomonas aeruginosa in 2 patients, with Candida albicans in 2, and with coagulase-negative Staphylococcus in 1 patient. In 4 patients other gram-positive bacteria were isolated. All isolated strains were resistant to various antibiotics tested. Teicoplanin, 200 mg, was administered once a day by femoral intra-arterial injection for an average period of 14.72 ±7.16 days (range ten to thirty-six days). Six patients were treated with an additional antibiotic intramuscularly or intravenously because of a mixed infection. At the end of the therapy microbiological assessment confirmed that gram-positive infection was eliminated in all patients. Clinical outcome demonstrated that healing occurred in 18 patients (72%) and improvement in 7 patients (28%).

No adverse drug reactions were observed during the treatment. The results demon strate that femoral intra-arterial administration of teicoplanin was highly effective in skin- and bone-infected lesions in the diabetic foot. This method may represent a further advantage in management of this severe diabetic complication.

Angiology, Vol. 46, No. 12, 1115-1122 (1995)
DOI: 10.1177/000331979504601207


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?